Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
Tamoxifen is a drug commonly used in the treatment of breast cancer, especially for postmenopausal patients. However, its efficacy is limited by the development of drug resistance. Downregulation of estrogen receptor alpha (ERα) is an important mechanism of tamoxifen resistance. In recent years, wit...
Saved in:
Main Authors: | Jingwei Yao (Author), Kun Deng (Author), Jialu Huang (Author), Ruimin Zeng (Author), Jianhong Zuo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A multidimensional comparative study of help-seeking messages on Weibo under different stages of COVID-19 pandemic in China
by: Jianhong Jiang, et al.
Published: (2024) -
Modelling the evolution of drug resistance in the presence of antiviral drugs
by: Archibald Chris, et al.
Published: (2007) -
Prognostic impact of PTK6 expression in triple negative breast cancer
by: Yuexia Chen, et al.
Published: (2023) -
A Reconsideration Of Tamoxifen Use for Breast Cancer
by: Peng-Hui Wang, et al.
Published: (2007) -
The benefits and costs of tamoxifen for breast cancer prevention
by: Simon D. Eckermann, et al.
Published: (2003)